Xenon Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE) will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco from January 9-12, 2023. The presentation is scheduled for January 9, 2023, at 7:30 am PT (10:30 am ET), led by President and CEO Ian Mortimer. Investors can access a live webcast of the presentation on the company’s website, with a replay available afterward. Xenon focuses on developing innovative treatments for neurological disorders, particularly epilepsy, aiming to address significant unmet medical needs.

BURNABY, British Columbia, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA from January 9-12, 2023.

Company Presentation Details:

Date:	Monday, January 9, 2023
Time:	7:30 am Pacific Time (10:30 am Eastern Time)
Presenters:	Ian Mortimer, President and CEO

A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

What date will Xenon Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Xenon Pharmaceuticals will present on January 9, 2023.

What time is Xenon Pharmaceuticals' presentation at the conference?

The presentation is scheduled for 7:30 am Pacific Time (10:30 am Eastern Time).

Who will be presenting on behalf of Xenon Pharmaceuticals?

Ian Mortimer, the President and CEO, will present for Xenon Pharmaceuticals.

Where can I watch the Xenon Pharmaceuticals presentation?

The presentation can be watched live on the Investors section of Xenon Pharmaceuticals' website.

What is the focus of Xenon Pharmaceuticals' drug development?

Xenon Pharmaceuticals focuses on developing therapeutics for neurological disorders, specifically targeting epilepsy.